KPV 10mg
Synthetic tripeptide (Lys-Pro-Val) — C-terminal fragment of alpha-MSH studied in inflammation pathway research Three amino acids — among the smallest bioactive peptides in the research catalog Research-grade · CAS 67727-97-3 For in vitro research only
For laboratory research use only. Not for human or veterinary consumption. SKU KPV10.
Product details.
Specifications
| Sequence | Lys-Pro-Val |
| Amino Acids | 3 |
| Molecular Formula | C16H30N4O4 |
| Molecular Weight | 342.44 g/mol |
| CAS Number | 67727-97-3 |
| Form | Lyophilized powder |
| Quantity | 10mg per vial |
| Purity | Research-grade |
| Storage | Store lyophilized powder at -20C, protected from light |
Research Background
KPV was first identified as the minimum active fragment retained from alpha-MSH following enzymatic processing. Research has explored its role in NF-kappaB signaling, intestinal epithelial models, and topical formulations. Independent investigators have published on KPV across in vitro and animal models since the late 1990s. Disclaimer: This product is sold strictly for in vitro laboratory research and is not intended for human or veterinary use, ingestion, injection, topical application, or any clinical, diagnostic, or therapeutic purpose. Sale is restricted to qualified research professionals. By purchasing, you affirm you are a qualified researcher and accept full responsibility for the proper handling, storage, and use of this material.
FDA Disclaimer. All products are for research use only (RUO) as defined by the FDA — not for diagnostic, human, or veterinary use. These products have not been evaluated and have not been approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
Heritage Labs is a chemical supplier providing products strictly for laboratory research, analytical, and in-vitro purposes; it is not a compounding pharmacy or compounding facility under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act.